跳至主要内容
临床试验/NCT06329739
NCT06329739招募中不适用

Genetics in Parkinson's Disease: Behavioral and Cognitive Outcomes in Patients Undergoing Dopaminergic Treatment

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2021年12月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
68
试验地点
1
主要终点
Pittsburgh Sleep Quality Index

研究概览

简要总结

The genetic landscape of Parkinson's disease (PD) is characterised by rare high penetrance pathogenic variants causing familial disease, genetic risk factor variants driving PD risk in a significant minority in PD cases and high frequency, low penetrance variants, which contribute a small increase of the risk of developing sporadic PD. This knowledge has the potential to have a major impact in the clinical care of people with PD.

The goal of this observational study is to evaluate the impact of genetic mutation on behavior and cognition in PD patients.

Patients will be assessed over time using test, questionnaire and standardised clinica scales. An initial assessment and annual follow-up assessments will be carried out for 5 years.

Researchers will compare data collected from patients with genetic mutation versus patients without mutation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosed with Parkinson's Disease (PD)
  • in use of dopaminergic medication (L-Dopa and/or dopamine agonists)
  • genetic testing for mendelian forms of PD
  • able to provide informed consent to participate in the study

排除标准

  • Patients underwent Deep Brain Stimulation (DBS) treatment

结局指标

主要结局

Pittsburgh Sleep Quality Index

时间窗: Annual assessments up to 5 years

Sleep Quality change (PSQI, min 0, max 21, higher score means poorer sleep quality)

Parkinson's Disease Questionnaire-8

时间窗: Annual assessments up to 5 years

Quality of life change from baseline to 5 years (PDQ-8, min 0, max 100, higher score means worse outcome)

Montreal Cognitive Assessment

时间窗: Annual assessments up to 5 years

Cognitive impairment change from baseline until 5 years in Montreal Cognitive Assessment (MoCA; min. 0, max. 30, higher score means better outcome)

Beck Depression Inventory

时间窗: Annual assessments up to 5 years

Depressive symptoms change from baseline to 5 year (BDI-II, min 0, max 63, higher score means worse outcome)

State-Trait Anxiety Inventory

时间窗: Annual assessments up to 5 years

Anxiety symptoms change from baseline to 5 year (STAI, min 20, max 80, higher score means worse outcome)

Minnesota Multiphasic Personality Inventory 2-RF

时间窗: Annual assessments up to 5 years

Personality change from baseline to 5 years (MMPI-2-RF, cut-off: T\>65 for clinical scales)

Questionnaire for Impulsive-Compulsive Disorders in Parkinson

时间窗: Annual assessments up to 5 years

Impulsivity change from baseline to 5 years (QUIP, min 0, max 112, higher score means worse outcome)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验